Clinical Trial Update: A Combination of Acalabrutinib With R-CHOP for Patient Diffuse Large B-cell Lymphoma (DLBCL) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the combination of acalabrutinib with R-CHOP in patients with non-Hodgkin lymphoma (diffuse large B-cell lymphoma).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Acalabrutinib (acalabrutinib)
• R-CHOP

Snippet

Sponsor: University Hospital Southampton NHS Foundation Trust | Conditions: Non Hodgkin Lymphoma | Phase 1, Phase 2 | Status: COMPLETED